1.
Indian J Dermatol Venereol Leprol
; : 1-3, 2024 Feb 28.
Article
in English
| MEDLINE
| ID: mdl-38595017
2.
Indian J Dermatol Venereol Leprol
; 85(6): 653-655, 2019.
Article
in English
| MEDLINE
| ID: mdl-31552837
Subject(s)
Epidermis/metabolism , Psoriasis/metabolism , Receptor, Bradykinin B1/metabolism , Receptor, Bradykinin B2/metabolism , Adult , Female , Humans , Male , Middle Aged
3.
Indian J Dermatol Venereol Leprol
; 81(1): 43-5, 2015.
Article
in English
| MEDLINE
| ID: mdl-25566896
ABSTRACT
Allopurinol, a drug commonly used for treating gout and hyperuricemia, is a frequent cause of drug eruptions. Recent investigations suggest that HLA-BFNx015801 allele is a very strong marker for allopurinol-induced cutaneous adverse drug reactions (cADRs). In this article we report two cases of allopurinol-induced drug eruptions in patients carrying the HLA-BFNx015801 allele and review the literature on the association between HLA-BFNx015801 and allopurinol-induced cADRs based on a MEDLINE and PubMed search.